Lakewood-Amedex Biotherapeutics, Inc. (LABT)

0.2373 -0.05 (-16.74%) USD  |  NASDAQ  |  Oct 29, 16:00
0.2239 -0.01 (-5.65%) After-Hours: 20:00
More

Lakewood-Amedex Biotherapeutics EV to EBITDA

EV to EBITDA Chart

View EV to EBITDA for LABT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EV to EBITDA Data

View and export this data back to . Start Trial.
Date Value

EV to EBITDA Definition

The EV to EBITDA measures the ratio between enterprise value and earnings before interest, taxes, depreciation, and amortization. This metric is important to analyze when looking at a company's true value based on how much they are valued at compared to how money they are earning.

Read full definition.

EV to EBITDA Range, Past 5 Years

View EV to EBITDA Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to EBITDA Benchmarks

View EV to EBITDA Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. --
Oncolytics Biotech, Inc. --
Sangamo Therapeutics, Inc. --
Sarepta Therapeutics, Inc. --
Anixa Biosciences, Inc. --

EV to EBITDA Related Metrics

EV to CFO Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade